Ending drug trial secrecy is a boon for R&D, says EU agency

Administrator 0 Reuters Health
Print Email

LONDON (Reuters) - Europe's medicines regulator has come out fighting for greater transparency for clinical trials, arguing that its controversial policy to end data secrecy will be "a boon to drug developers".


Read Full Article


You can contact us at: